GLINE MATTHEW (CEO) sold 1.7% of their position (289.77K shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $8.45M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/20/2026ACC: 0001635088-26-000038
DirectorOfficer· CEO
Since Oct 2021
-289.77K
Net shares
Net seller
$8.45M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
289.77K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−289.77K
Price / share
$29.16
Trade value
$8.45M
% of position
1.7%
4/16/2026
17.03M→16.74M
Total
Net shares
−289.77K
Net value
-$8.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 4/16/2026 | S · Sale | −289.77K | $29.16 | $8.45M | 1.7% | 17.03M | 16.74M |
| Total | −289.77K | -$8.45M | ||||||
Derivative Transactions0
No derivative transactions reported